Optimization of Sedation Protocol for Endoscopic Procedures Using Impedance Ventilation Monitor.
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of the study is to evaluate the effect of opioids administered during sedation on patients' respiratory activity (ventilation) and comfort of the operator and patient during the endoscopic procedure. A common side effect of sedation is the effect on patients' ventilation, resulting from a combination of attenuation of respiratory centre activity and loss of patent airways. Shallow sedation will reduce these risks, but in addition to patient discomfort, it also increases the difficulty or impossibility of the endoscopist to perform the procedure. Choosing the appropriate method of sedation thus fundamentally affects the course of the procedure from the point of view of both the patient and the endoscopist. The aim is to prove that sedation with propofol alone compared to sedation with propofol and fentanyl premedication leads to the need for higher cumulative doses of administered propofol, higher risk of respiratory depression and lower patient and operator comfort. In addition, the non-invasive respiratory volume monitor (ExSpiron 2Xi) will be used for standard patient monitoring during the procedure, which assesses the lung tidal volume and respiratory rate by measuring the electrical impedance of the chest. This measurement captures inadequate ventilation before saturation drops, allowing even slight differences between selected drugs to be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2023
CompletedFirst Posted
Study publicly available on registry
September 29, 2023
CompletedStudy Start
First participant enrolled
November 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2025
CompletedJanuary 28, 2025
September 1, 2023
1.2 years
September 25, 2023
January 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of significant decrease in ventilation during propofol sedation.
Incidence of significant decrease in ventilation during sedation with propofol alone during endoscopic surgery.
during the endoscopic procedure
Incidence of significant decrease in ventilation during propofol and fentanyl sedation.
Incidence of significant decrease in ventilation during sedation with propofol and fentanyl during endoscopic surgery.
during the endoscopic procedure
Secondary Outcomes (2)
Subjective assessment of the comfort of the procedure by the endoscopist.
immediately after the procedure
Subjective assessment of the comfort of the procedure by the patient.
immediately after the procedure
Study Arms (2)
Propofol
ACTIVE COMPARATORPatients in whom only propofol will be administered during sedation. Intermittent boluses of propofol titrated to moderate level of sedation.
Fentanyl
ACTIVE COMPARATORPatients in whom combination of propofol and fentanyl will be administered during sedation. Fentanyl 1 ug/kg bolus 3 minutes before induction + Propofol intermittent boluses titrated to moderate level of sedation.
Interventions
Patients in whom only propofol will be administered during sedation.
Patients in whom combination of propofol and fentanyl will be administered during sedation.
Eligibility Criteria
You may qualify if:
- Scheduled therapeutic or diagnostic colonoscopy with sedation
- Supine or lateral decubitus position
- Age 18-65
- American Society of Anesthesiologists (ASA) physical status classification system 1-2
- Informed consent signed
You may not qualify if:
- Planned frequent use of electrocoagulation
- Contact allergy for adhesive pads, excessive thoracic hair or other problem with pads
- contraindication of using Propofol or Fentanyl
- Incapability to understand the informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Military University Hospital Prague
Prague, Czechia, 16209, Czechia
Related Publications (3)
Zhang X, Kassem MA, Zhou Y, Shabsigh M, Wang Q, Xu X. A Brief Review of Non-invasive Monitoring of Respiratory Condition for Extubated Patients with or at Risk for Obstructive Sleep Apnea after Surgery. Front Med (Lausanne). 2017 Mar 8;4:26. doi: 10.3389/fmed.2017.00026. eCollection 2017.
PMID: 28337439BACKGROUNDVoscopoulos CJ, MacNabb CM, Brayanov J, Qin L, Freeman J, Mullen GJ, Ladd D, George E. The evaluation of a non-invasive respiratory volume monitor in surgical patients undergoing elective surgery with general anesthesia. J Clin Monit Comput. 2015 Apr;29(2):223-30. doi: 10.1007/s10877-014-9596-0. Epub 2014 Jul 19.
PMID: 25037938BACKGROUNDBai Y, Xu Z, Chandrashekar M, St Jacques PJ, Liang Y, Jiang Y, Kla K. Comparison of a simplified nasal continuous positive airways pressure device with nasal cannula in obese patients undergoing colonoscopy during deep sedation: A randomised clinical trial. Eur J Anaesthesiol. 2019 Sep;36(9):633-640. doi: 10.1097/EJA.0000000000001052.
PMID: 31313720BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ilona Trtíková, Mgr., Ph.D.
CHARLES UNIVERSITY, FIRST FACULTY OF MEDICINE AND MILITARY UNIVERSITY HOSPITAL PRAGUE
- PRINCIPAL INVESTIGATOR
David Novotný, M.D.
CHARLES UNIVERSITY, FIRST FACULTY OF MEDICINE AND MILITARY UNIVERSITY HOSPITAL PRAGUE
- PRINCIPAL INVESTIGATOR
Tomáš Tyll, M.D., Ph.D.
CHARLES UNIVERSITY, FIRST FACULTY OF MEDICINE AND MILITARY UNIVERSITY HOSPITAL PRAGUE
- PRINCIPAL INVESTIGATOR
Michal Soták, M.D., Ph.D.
CHARLES UNIVERSITY, FIRST FACULTY OF MEDICINE AND MILITARY UNIVERSITY HOSPITAL PRAGUE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- The endoscopist performing the procedure will not be informed which group the patient belongs to.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2023
First Posted
September 29, 2023
Study Start
November 16, 2023
Primary Completion
January 22, 2025
Study Completion
January 22, 2025
Last Updated
January 28, 2025
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share